does medicare pay for glp-1 Bridge Program: $50 Wegovy, Zepbound, Foundayo (2026) Weight Loss Drug Coverage |
Description
Results are limited by the relatively small sample size and the sub-optimal number of band-adjustments which is, in part, related to the COVID pandemic and may underpin the sub-optimal weight and glycaemic responses in both groups
In a large study directly comparing the two, both medications helped participants achieve meaningful weight reduction
SURMOUNT-MMO, NCT05556512) (Table 3)
These new agents will change our therapy of T2DM and obesity
Medications like Tirzepatide target GLP-1 to help manage Type 2 diabetes and obesity
